Cytokinetics Inc (CYTK)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$7.83B
EV to revenue ratio (TTM)
69.06
EV to ebitda
-15.82
Financial Performance
Revenue (TTM)
$0.11B
Gross profit (TTM)
-$0.29B
EBITDA
-$0.69B
Profitability
Operating margin (TTM)
-351.30%
Profit margin
<0.01%
Return on assets (TTM)
-27.20%
Return on equity (TTM)
-572.00%
Per Share Metrics
Revenue per share (TTM)
$0.88
EPS
-$6.02
Diluted EPS (TTM)
-$6.02
Book value
-$2.31
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
117.65
PEG ratio
-0.42
Price to sales ratio (TTM)
69.08
Price to book ratio (TTM)
60.31
Growth
Quarterly earnings growth (YoY)
2,357.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
7
Buy
13
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.47